Network origin in Neil David Murray first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Neil David Murray via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Public Communications Contact | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Carroll London Markets Ltd.
Carroll London Markets Ltd. Insurance Brokers/ServicesFinance Carroll Mondon Markets Ltd. provides insurance brokerage services. It offers broking services in the areas of motor fleet, private clients/high-mid net worth, and third party binders. The company was founded in 1832 and is headquartered in London, the United Kingdom. | Insurance Brokers/Services | Director/Board Member | |
Gardant Pharmaceuticals, Inc.
Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Pharmaceuticals: Major | Chief Executive Officer | |
IOMAI CORPORATION | Biotechnology | Director/Board Member | |
Vocalink Interchange Network Ltd.
Vocalink Interchange Network Ltd. Regional BanksFinance Vocalink Interchange Network Ltd. provides transaction management services. It forms a hub for the UK's payments infrastructure. It is the transaction management company whose primary focus of attention is switching and settling shared transactions for ATM network. The company processes over 2.4 billion secure transactions per year for the 51 LINK network Members. It provides the legal and commercial framework that makes ATM sharing in the UK via the LINK network. The company is headquartered in Harrogate, the United Kingdom. | Regional Banks | Chairman | |
The Rockefeller University | College/University | Corporate Officer/Principal | |
University of Leiden | College/University | Corporate Officer/Principal | |
University of Utrecht | College/University | Doctorate Degree | |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universität Konstanz | College/University | Doctorate Degree | |
University of Helsinki | College/University | Graduate Degree | |
Arthur Andersen (UK)
Arthur Andersen (UK) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen (UK) is a British company that provides accounting services. The company is based in Reading, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
VocaLink Ltd.
VocaLink Ltd. Regional BanksFinance VocaLink Ltd. provides electronic financial payment services. Its services include payment processing, access services, banking services, international, and mobile payments. The company was founded in 1968 and is headquartered in Rickmansworth, the United Kingdom. | Regional Banks | Chairman | |
King's College London | College/University | Graduate Degree | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Valneva Scotland Ltd.
Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director of Finance/CFO | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Investor Relations Contact | |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Valneva Austria GmbH
Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
East Kent Hospitals University NHS Foundation Trust | Hospital/Nursing Management | Director/Board Member | |
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Vaccines Holdings Sweden AB
Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
ICONIC LABS PLC | Advertising/Marketing Services | Chairman | |
BioMedx Group, Inc.
BioMedx Group, Inc. Medical SpecialtiesHealth Technology BioMedx Group, Inc. operates as a medical technology company transforming the cosmetic surgery consultation services. The firm engages in product development focus on the modeling and simulation of the human face for aesthetic and facial reconstruction applications. The company was founded by Rudy A. Mazzocchi and is headquartered in Baltimore, MD. | Medical Specialties | Director/Board Member | |
BioMed X GmbH
BioMed X GmbH Miscellaneous Commercial ServicesCommercial Services BioMed X GmbH is an independent research institute that conducts biomedical pre-clinical research projects in the fields of biomedicine, molecular biology, cell biology, and diagnostics. The private company is based in Heidelberg, Germany. The German company sponsors these projects with pharmaceutical partners such as Merck, Boehringer Ingelheim, Johnson & Johnson, AbbVie, and Roche. Talented early-career scientists from all over the world are recruited to work on these projects. The company combines crowdsourcing with local incubation to provide creative solutions to big biomedical research challenges. Each research team has access to state-of-the-art research infrastructure and is guided by experienced mentors from academia and industry. The company was founded in 2013 by Christian Tidona, who has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member | |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Medical Specialties | Director/Board Member | |
BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
Infex Therapeutics Ltd.
Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Biotechnology | Director/Board Member Chief Operating Officer | |
Valneva Canada, Inc.
Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member | |
Stuart & Muir Consulting Ltd. | Director/Board Member | ||
Agprome Ltd. | Director/Board Member | ||
Synpromics Agbiosub Ltd.
Synpromics Agbiosub Ltd. Miscellaneous Commercial ServicesCommercial Services Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Beautiful Information Ltd.
Beautiful Information Ltd. Packaged SoftwareTechnology Services Part of Vitalhub Corp., Beautiful Information Ltd. is a British company that provides real-time information of patient flow solutions. The company is based in Ashford, UK. Beautiful Information was acquired by The Oakgroup (UK) Ltd. on January 27, 2022 for $2.08 million. | Packaged Software | Chairman | |
R&B Underwriting | Chairman | ||
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Director/Board Member | |
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Valneva USA, Inc. | Director/Board Member | ||
ACM Biolabs Pte Ltd.
ACM Biolabs Pte Ltd. BiotechnologyHealth Technology ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
C E Heath Plc | Chief Executive Officer | ||
ASHINGTON INNOVATION PLC | Financial Conglomerates | Chairman |
Statistics
International
United Kingdom | 25 |
United States | 6 |
Germany | 6 |
Israel | 5 |
Netherlands | 4 |
Sectoral
Health Technology | 23 |
Consumer Services | 7 |
Commercial Services | 7 |
Finance | 6 |
Technology Services | 3 |
Operational
Director/Board Member | 91 |
Chairman | 38 |
Corporate Officer/Principal | 37 |
Chief Executive Officer | 24 |
Independent Dir/Board Member | 16 |
Most connected contacts
Insiders | |
---|---|
Frank Armstrong | 41 |
Iain Ross | 41 |
David Lawrence | 29 |
Peter Jackson | 16 |
Bernhard Kirschbaum | 15 |
Peter Presland | 13 |
Norman Molyneux | 9 |
Peter McPartland | 9 |
Karl Hård | 7 |
Nicholas Adams | 7 |
Derek Lindsay | 6 |
Richard E. Armer | 5 |
Dominic Nicholas Jackson | 4 |
Andrew Booth | 3 |
Phillip John Tottey | 2 |
- Stock Market
- Insiders
- Neil David Murray
- Company connections